880261-48-3

Upstream product

• 140-75-0 para-fluorobenzylamine 
• 880261-46-1 4-benzyloxy-N-(4-fluorobenzyl)-5-methoxy-6-methylnicotinamide 
• 880261-45-0 N-(4-fluorobenzyl)-4-hydroxy-5-methoxy-6-methylnicotinamide 
• 880261-44-9 5-bromo-N-(4-fluorobenzyl)-4-hydroxy-6-methylnicotinamide 
• 141703-16-4 5-bromo-4-hydroxy-6-methylnicotinic acid 
• 67367-33-3 4-hydroxy-6-methylnicotinic acid 
• 880261-47-2 4-benzyloxy-N-(4-fluorobenzyl)-5-methoxy-6-methylnicotineamide-N-oxide 

Downstream Products

• 880261-49-4 4-benzyloxy-N-(4-fluorobenzyl)-6-formyl-5-methoxynicotineamide 
• 880261-51-8 methyl 5-{((4-fluorobenzyl)carbamoyl)}-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate 
• 880261-52-9 4-benzyloxy-5-(4-fluorobenzylcarbamoyl)-3-methoxypyridine-2-carboxylic acid 
• 880261-53-0 4-Benzyloxy-3-methoxy-pyridine-2,5-dicarboxylic acid 2-amide 5-(4-fluoro-benzylamide) 
• 1400003-21-5 C₂₃H₂₂FN₃O₄ 
• 1400003-23-7 C₂₄H₂₄FN₃O₄ 
• 880261-50-7 methyl 4-(benzyloxy)-5-{((4-fluorobenzyl)carbanoyl)}-3-methoxypyridine-2-carboxylate 

Relevant academic research and scientific papers

Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore

Our group has focused on expanding the scope of a two-metal binding pharmacophore concept to explore HIV-1 integrase inhibitors through medicinal chemistry efforts to design novel scaffolds which allow for improvement of pharmacokinetic (PK) and resistanc

CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY

An object of the present invention provides a novel compound having the anti-viral activity, particularly, the HIV integrase inhibitory activity, and a drug containing the same, particularly, an anti-HIV drug. There is provided a compound represented by t